Receives award for second year in a row
The Harden and Sondek labs publish a paper in Science that describes the mechanism of activation and inactivation of the Gq/phospholipase-β signaling complex.
Department of Defense grants award to study Post-Traumatic Stress Syndrome.
Department of Defense grants Breast Cancer IDEA Award to study breast cancer stem cells.
Sunday, June 27, 2010 — In a paper published in the journal Nature Biotechnology, UNC's Klaus M. Hahn, PhD, describes a new technique called engineered allosteric regulation, which provides a new tool for scientists who study the interactions of proteins within living cells.
Yanping Zhang, PhD, Associate Professor in the Department of Radiation-Oncology and Joint Associate Professor in Pharmacology receives the Third Annual Battle Award.
Paper reexamining glial function published in Science and highlighted in Nature
Klaus Hahn receives prestigious NIH Transformative Award in 2009
Jude Samulski Elected Vice President of American Society of Gene and Cell Therapy (ASGCT) in 2009
Dr. Klaus Hahn, Thurman Distinguished Professor in Pharmacology publishes back to back papers in Nature with collaborators.
Dr. Crews honored for his contributions to understanding the causes, prevention and treatment of alcoholism.
Dr. Zefeng Wang wins award to improve basic understanding of cancer biology
Dr. Roth interviewed about research on Salvia and possible health benefits for Alzheimer's disease and other mental disorders, and the difficulties that may ensue for researchers should Salvia be classified a Schedule I drug.
Dr. Samulski wins $5 million grant to establish a national center for canine models of muscular dystrophy.